Presenting Monogenic Heart Failure Disease Modeling in Kyoto

https://www.termis.org/wc2018/

On September 7th, CSO speaks about monogenic disease modeling using NuHeart™ technology during TERM for heart, blood vessel & lung session.

99-O-5: Personalized micro-3D human heart 
tissues for orphan drug development
Tetsuro Wakatsuki,Neil Daily,Pinar Kemanli,
Michael Greenberg,Jennifer Strande
InvivoSciences, Inc. Madison Wisconsin, USA, Washington University, St. Louis, Medical College of Wisconsin.